These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 3213308)

  • 1. [Plasma kininogenesis and fibrinolysis in the pathogenesis of EPH gestosis].
    Czokało M; Jaworski S; Buluk K; Rudzinski A
    Zentralbl Gynakol; 1988; 110(21):1345-53. PubMed ID: 3213308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentrations of leptin and neuropeptide Y in maternal plasma, umbilical cord blood and in amniotic fluid in pregnant women with EPH-gestosis.
    Kokot F; Ulman I; Wiecek A; Irzyniec T; Ulman J
    Arch Immunol Ther Exp (Warsz); 1998; 46(5):311-6. PubMed ID: 9832071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in hemostasis and fibrinolysis in gestational diabetes].
    Kvasnicka J; Bendl J; Zivný J; Umlaufová A; Maslowská H
    Cas Lek Cesk; 1996 Feb; 135(4):106-10. PubMed ID: 8625379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Coagulation-fibrinolysis and kinin-forming systems in toxemia of pregnancy].
    Hayakawa M
    Nihon Sanka Fujinka Gakkai Zasshi; 1988 Jan; 40(1):59-66. PubMed ID: 3351365
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of immunologic parameters in pregnancies complicated by EPH-gestosis.
    Bartl W; Bernaschek G; Wagner G; Liszka K
    Biol Res Pregnancy Perinatol; 1985; 6(2):73-8. PubMed ID: 3893553
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Plasma fibronectin in normal pregnancy and EPH gestosis].
    Tatra G; Graninger W; Nasr F; Hoyer E; Pirich K
    Geburtshilfe Frauenheilkd; 1983 Oct; 43(10):594-7. PubMed ID: 6557967
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Complement levels of C4, C3C, factor B, and C1 inactivator in peripheral and retroplacental blood of parturient women with EPH gestosis.
    Zdanowicz A; Jabłońska E; Pietruska Z; Bielecki M
    Ann Med Univ Bialyst Pol; 1993; 38(1):60-7. PubMed ID: 7922487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IgA nephropathy and pregnancy.
    Koido S; Makino H; Iwazaki K; Makino T
    Tokai J Exp Clin Med; 1998 Mar; 23(1):31-7. PubMed ID: 9972534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Changes in the indicators of the fibrinolytic and kallikrein-kinin systems in patients with calculous pyelonephritis].
    Neĭmark AI; Mazyrko AV
    Ter Arkh; 1984; 56(6):111-4. PubMed ID: 6566490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of coagulation and fibrinolysis by plasma proteinase inhibitors.
    Travis J; Salvesen G
    Behring Inst Mitt; 1983 Aug; (73):56-65. PubMed ID: 6206838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Incidence and significance of fundus changes in EPH gestosis].
    Riss B; Drobec P; Riss P
    Klin Monbl Augenheilkd; 1983 Sep; 183(3):180-3. PubMed ID: 6645259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma levels and urinary excretion of fibrinolytic and protease inhibitory proteins in nephrotic syndrome.
    Vaziri ND; Gonzales EC; Shayestehfar B; Barton CH
    J Lab Clin Med; 1994 Jul; 124(1):118-24. PubMed ID: 7518491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Histidine-rich-3,8S-alpha 2-glycoprotein in normal pregnancy and EPH-gestosis].
    Tatra G; Nasr F; Hoyer E
    Z Geburtshilfe Perinatol; 1983; 187(3):124-6. PubMed ID: 6684366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the contact system of plasma proteolysis in the adult respiratory distress syndrome.
    Carvalho AC; DeMarinis S; Scott CF; Silver LD; Schmaier AH; Colman RW
    J Lab Clin Med; 1988 Aug; 112(2):270-7. PubMed ID: 3397629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of the relative contribution of different protease inhibitors to the inhibition of plasmin in vivo.
    Levi M; Roem D; Kamp AM; de Boer JP; Hack CE; ten Cate JW
    Thromb Haemost; 1993 Feb; 69(2):141-6. PubMed ID: 7681223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of plasmin during acute attacks of hereditary angioedema.
    Cugno M; Hack CE; de Boer JP; Eerenberg AJ; Agostoni A; Cicardi M
    J Lab Clin Med; 1993 Jan; 121(1):38-43. PubMed ID: 8426080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immunoglobulins and complement in pregnant women with EPH gestosis (author's transl)].
    Janković D; Horvat Z; Bolanca M; Barsić E
    Jugosl Ginekol Opstet; 1981; 21(3-4):69-74. PubMed ID: 7339278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Complement and immunoglobulin levels in pregnant women with EPH gestosis].
    Rosić B; Sulović V; Juznić N; Lazarević B; Vidanović M
    Srp Arh Celok Lek; 1989; 117(7-8):459-64. PubMed ID: 2595470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Proteolysis and antiproteolysis associated with toxemia of pregnancy.
    Vázquez Escobosa C; Pérez Medina R; Gómez Estrada H; Fernández de Castro J
    Arch Invest Med (Mex); 1980; 11(4):445-59. PubMed ID: 7011239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.